The GSC23 cell line, established from a patient-derived xenograft of a recurrent and aggressive tumor24, and also used in our previous work8, was intermediate in its expression of GNA12, providing a representative model to examine the role of G⍺12 signaling in GBM growth. This evidence concerns the gene GNA12 and glioblastoma.